“Nail loss after teriflunomide treatment: A new potential adverse event”

Volume: 18, Pages: 170 - 172
Published: Nov 1, 2017
Abstract
Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment...
Paper Details
Title
“Nail loss after teriflunomide treatment: A new potential adverse event”
Published Date
Nov 1, 2017
Volume
18
Pages
170 - 172
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.